IAIM
BIOL

International Assets Investment Management’s Biolase, Inc. BIOL Stock Holding History

International Assets Investment Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$1K – 2016
2021
Q1 		$1K Hold
1
– – ﹤0.01% 2157
2020
Q4 		$1K Buy
+1
New +$763 ﹤0.01% 2049

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

International Assets Investment Management's BIOL Position: Q2 2021 in Review

International Assets Investment Management sold out of Biolase, Inc. (BIOL) in Q2 2021, closing a stake of 1 share — an estimated $1K sold.

International Assets Investment Management first reported a position in BIOL in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 31 funds tracked by Wall St. Rank hold BIOL as of Q2 2021.

  • International Assets Investment Management reported no remaining Biolase, Inc. position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 1 Biolase, Inc. share in Q2 2021, an estimated $1K.
  • International Assets Investment Management first reported a position in Biolase, Inc. in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Biolase, Inc. position peaked at $1K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.